Searching…
CoviVac (Russian: КовиВак) is an inactivated virus -based COVID-19 vaccine developed by the Chumakov Centre [ru], [2] which is an institute of the Russian Academy of Sciences. [3]
Aug 29, 2023 · These findings indicate that CoviVac can be successfully used both for primary vaccination in a two-dose regimen and for booster vaccination as a single dose in individuals with reduced neutralizing ant...
These therapeutic entities can be divided into three different classes10: the first one is composed of the inactivated virus vaccines, such as Chinese CoronaVac and the Russian CoviVac, the second family is formed by ...
CoviVac is an inactivated virus-based vaccine based on an inactivated SARS-CoV-2 strain AYDAR-1 and mixed with an aluminium-based adjuvant. CoviVac is also recommended in two doses, 14 days apart.
Dec 13, 2023 · Multiple vaccines against the Wuhan variant of SARS-CoV-2 have been developed including a whole virion beta-propiolactone-inactivated vaccine based on the B.1.1 strain (CoviVac).
Sep 4, 2023 · These findings indicate that CoviVac can be successfully used both for primary vaccination in a two-dose regimen and for booster vaccination as a single dose in individuals with reduced neutralizing anti...
Covivac (Vietnam COVID-19 vaccine), viral vector COVID-19 vaccine developed by Institute of Vaccines and Medical Biologicals in Vietnam, later named NDV-HXP-S COVI-VAC (U.S. COVID-19 vaccine), codenamed CDX-005; live-...
CoviVac is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre, which is an institute of the Russian Academy of Sciences. It was approv...
Feb 20, 2021 · Russia on Saturday approved a third coronavirus vaccine for domestic use, Prime Minister Mikhail Mishustin said on state TV, though large-scale clinical trials of the shot, labelled CoviVac and...
Aug 29, 2023 · In conclusion, inactivated vaccine CoviVac has shown good tolerability and safety, with over 85% NT seroconversion rates after complete vaccination course in participants who were seronegative at screen...
